BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33589451)

  • 1. Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case-control study.
    Ikuta K; Nakagawa S; Momo K; Yonezawa A; Itohara K; Sato Y; Imai S; Nakagawa T; Matsubara K
    BMJ Open; 2021 Feb; 11(2):e041543. PubMed ID: 33589451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study.
    Ikuta K; Nakagawa S; Yamawaki C; Itohara K; Hira D; Imai S; Yonezawa A; Nakagawa T; Sakuragi M; Sato N; Uchino E; Yanagita M; Terada T
    BMC Nephrol; 2022 Nov; 23(1):383. PubMed ID: 36451129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
    Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
    Hart E; Dunn TE; Feuerstein S; Jacobs DM
    Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-steroidal anti-inflammatory drugs and risk of myocardial infarction adjusting for use of proton pump-inhibitors in patients with no major risk factors: a nested case-control study in the UK Clinical Practice Research Datalink.
    Baak BN; Jick SS
    Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 9(1):58-75. PubMed ID: 35876661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-controlled Case Series Study for Acute Kidney Injury after Starting Proton Pump Inhibitors or Potassium-Competitive Acid Blocker in Patients with Cancer Using a Large Claims Database.
    Suzuki K; Watanabe A; Kiryu Y; Inoue E; Momo K
    Biol Pharm Bull; 2024; 47(2):518-526. PubMed ID: 38403662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
    Chen G; Ning LJ; Qin Y; Zhao B; Mei D; Li XM
    J Gastroenterol Hepatol; 2021 Jan; 36(1):156-162. PubMed ID: 32542684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal anti-inflammatory drugs, renin-angiotensin system blockade or diuretics and risk of acute kidney injury: A case-crossover study.
    Weng SE; Hsu WT; Hsiao FY; Lee CM
    Arch Gerontol Geriatr; 2024 Aug; 123():105394. PubMed ID: 38537386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
    Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
    Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.
    Bakhriansyah M; Souverein PC; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1141-1148. PubMed ID: 28370857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury.
    Dreischulte T; Morales DR; Bell S; Guthrie B
    Kidney Int; 2015 Aug; 88(2):396-403. PubMed ID: 25874600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Effects of Oral Nonselective and cyclooxygenase-2-Selective NSAIDs on Hospitalization for Acute Kidney Injury: A Nested Case-Control Cohort Study.
    Chou CI; Shih CJ; Chen YT; Ou SM; Yang CY; Kuo SC; Chu D
    Medicine (Baltimore); 2016 Mar; 95(9):e2645. PubMed ID: 26945352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system.
    Wu B; Li D; Xu T; Luo M; He Z; Li Y
    Sci Rep; 2021 Feb; 11(1):3690. PubMed ID: 33574396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control study.
    Vonkeman HE; Braakman-Jansen LM; Klok RM; Postma MJ; Brouwers JR; van de Laar MA
    Arthritis Res Ther; 2008; 10(6):R144. PubMed ID: 19077318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.
    Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G
    Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database.
    Chen P; Zhu J; Xu Y; Huang Q; Su J; Gao Z; Feng M
    BMC Nephrol; 2023 Apr; 24(1):107. PubMed ID: 37087434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Concomitant Use of Acyclovir or Valacyclovir with NSAIDs and an Increased Risk of Acute Kidney Injury: Data Mining of FDA Adverse Event Reporting System.
    Yue Z; Shi J; Li H; Li H
    Biol Pharm Bull; 2018 Feb; 41(2):158-162. PubMed ID: 29187701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study.
    Nagata N; Niikura R; Yamada A; Sakurai T; Shimbo T; Kobayashi Y; Okamoto M; Mitsuno Y; Ogura K; Hirata Y; Fujimoto K; Akiyama J; Uemura N; Koike K
    PLoS One; 2016; 11(3):e0151332. PubMed ID: 26978517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.